Drawing for WELLVEE

USPTO serial 88858276

WELLVEE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BLACK, MILDRED ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WELLVEE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura A. Genovese

Laura A. Genovese K & G Law LLC602 S. Bethlehem Pike, Bldg BAmbler, PA 19002UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Apparatus for blood analysis; Blood glucose meter; Blood oxygen monitors; Blood pressure measuring apparatus; Blood pressure monitors; Blood pressure transducers; Blood pressure and diabetic diagnostic medical devices; Blood pretreatment apparatus and instruments; Devices for measuring blood sugar; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Electronic temperature monitors for medical use; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory event; Medical apparatus and instruments for use in positron emission tomography (PET) imaging used to monitor brain, heart and metabolic functions; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of electronics for transmitting monitored data through the Internet, as a component of the medical devices; Medical instruments for measuring and displaying vital signs, blood properties and respiratory events; Medical apparatus for monitoring vital signs of patients; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Patient medical monitors for monitoring systolic blood pressure, diastolic blood pressure, blood glucose levels, blood perfusion, pulse rate, heart rate, blood oxygenation saturation (SPO2), heart rate variability, respiration rate, core body temperature, weight and electrocardiogram (ECG); Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Arterial blood pressure measuring apparatus; Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parametersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 3, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 3, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 29, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 4, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 4, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 29, 2020ALIEASSIGNED TO LIE—
Jun 24, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 23, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jun 23, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 23, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 23, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 21, 2020DOCKASSIGNED TO EXAMINER—
May 23, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 23, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 23, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 23, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 23, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 9, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 6, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance